PDX-1 IN MAMMALIAN PANCREATIC DEVELOPMENT

PDX-1 在哺乳动物胰腺发育中的作用

基本信息

  • 批准号:
    6466603
  • 负责人:
  • 金额:
    $ 19.88万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2001
  • 资助国家:
    美国
  • 起止时间:
    2001-07-01 至 2002-09-29
  • 项目状态:
    已结题

项目摘要

Our long-term goals are to produce information relevant to the identification, purification, expansion and differentiation of multi- potential pancreatic stem cells, which may lead to material suitable for pancreas replacement therapy, and increase our understanding of, and eventually help to offset, the cellular defects in type II diabetes. Although some progress in these areas has come recently from studies of mice with inactivated genes that encode transcription factors expressed in the pancreas, our mechanistic understanding of endocrine/exocrine differentiation during embryogenesis, and maintenance of cell type and function in adults, is still rudimentary. We propose a focused set of experiments directed at filling some of these gaps. First, we will carry out a precise functional analysis of an essential pancreatic gene, pdx-1. Global pdx-1 inactivation blocks pancreas development, and we will now determine the role of pdx-1 in later stages of pancreatic cell differentiation, in the exocrine, beta and non-beta cell genes, indicating that pdx-1 transcriptional regulation is a major focus for the control of beta cell function. We have identified likely pdx-1 cis-regulatory elements that contain binding sites for transcription factors that include HNF3beta and the recently described MODY susceptibility factors. We will determine the role of these conserved cis-regulatory elements in vivo. Third, we will develop genetic lineage tracing techniques to characterized endocrine cell ontogeny. Specific aims are: (1) to determine the effect of inactivating pdx-1 in selected endocrine and exocrine cells. (2) to determine in vivo the role of conserved cis-regulatory sequences in pdx-1, to begin to dissect the transcriptional regulatory networks controlling pancreas formation and function. (3) Develop genetic lineage tracing techniques for a rigorous understanding of pancreatic cell ontogeny, with special reference to the endocrine pathway.
我们的长期目标是产生与多潜能胰腺干细胞的鉴定、纯化、扩增和分化相关的信息,这可能导致适用于胰腺替代疗法的材料,并增加我们对II型糖尿病中的细胞缺陷的理解,并最终帮助抵消II型糖尿病中的细胞缺陷。虽然最近在这些领域取得了一些进展,从小鼠的研究与失活的基因编码的转录因子在胰腺中表达,我们的内分泌/外分泌分化在胚胎发育过程中的机制的理解,并在成人的细胞类型和功能的维护,仍然是初步的。我们提出了一套集中的实验,旨在填补这些空白。首先,我们将对一个重要的胰腺基因pdx-1进行精确的功能分析。整体pdx-1失活阻断胰腺发育,我们现在将确定pdx-1在胰腺细胞分化后期,外分泌,β和非β细胞基因中的作用,表明pdx-1转录调控是β细胞功能控制的主要焦点。我们已经确定了可能的pdx-1顺式调控元件,包含转录因子,包括HNF 3 β和最近描述的MODY易感因子的结合位点。我们将确定这些保守的顺式调控元件在体内的作用。第三,我们将发展遗传谱系追踪技术来表征内分泌细胞的个体发生。具体目标是:(1)确定在选定的内分泌和外分泌细胞中灭活pdx-1的效果。(2)为了在体内确定PDX-1中保守的顺式调节序列的作用,开始剖析控制胰腺形成和功能的转录调节网络。(3)发展遗传谱系追踪技术,以严格了解胰腺细胞个体发育,特别是内分泌途径。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Christopher V Wright其他文献

Christopher V Wright的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Christopher V Wright', 18)}}的其他基金

Control of endocrine pancreatic beta-cell fate, function, and proliferation
控制内分泌胰腺 β 细胞的命运、功能和增殖
  • 批准号:
    10359799
  • 财政年份:
    2018
  • 资助金额:
    $ 19.88万
  • 项目类别:
Architecture and communication controlling the efficient generation of beta cells
控制β细胞有效生成的架构和通信
  • 批准号:
    8316317
  • 财政年份:
    2010
  • 资助金额:
    $ 19.88万
  • 项目类别:
Architecture and communication controlling the efficient generation of beta cells
控制β细胞有效生成的架构和通信
  • 批准号:
    8143507
  • 财政年份:
    2010
  • 资助金额:
    $ 19.88万
  • 项目类别:
Architecture and communication controlling the efficient generation of beta cells
控制β细胞有效生成的架构和通信
  • 批准号:
    8522280
  • 财政年份:
    2010
  • 资助金额:
    $ 19.88万
  • 项目类别:
Architecture and communication controlling the efficient generation of beta cells
控制β细胞有效生成的架构和通信
  • 批准号:
    8717653
  • 财政年份:
    2010
  • 资助金额:
    $ 19.88万
  • 项目类别:
Architecture and communication controlling the efficient generation of beta cells
控制β细胞有效生成的架构和通信
  • 批准号:
    7994960
  • 财政年份:
    2010
  • 资助金额:
    $ 19.88万
  • 项目类别:
Transcriptional networks of pancreas endocrine
胰腺内分泌转录网络
  • 批准号:
    7056496
  • 财政年份:
    2005
  • 资助金额:
    $ 19.88万
  • 项目类别:
CONTROL OF CORNEAL ENDOTHELIUM DEVELOPMENT IN THE MOUSE
小鼠角膜内皮发育的控制
  • 批准号:
    6530102
  • 财政年份:
    2000
  • 资助金额:
    $ 19.88万
  • 项目类别:
PDX-1 IN MAMMALIAN PANCREATIC DEVELOPMENT
PDX-1 在哺乳动物胰腺发育中的作用
  • 批准号:
    6352881
  • 财政年份:
    2000
  • 资助金额:
    $ 19.88万
  • 项目类别:
PDX-1 IN MAMMALIAN PANCREATIC DEVELOPMENT
PDX-1 在哺乳动物胰腺发育中的作用
  • 批准号:
    6105437
  • 财政年份:
    1999
  • 资助金额:
    $ 19.88万
  • 项目类别:

相似海外基金

The Role of CA8 in Hepatic Glucose Production and Its Prospect as Type 2 Diabetes Mellitus Treatment
CA8在肝葡萄糖生成中的作用及其治疗2型糖尿病的前景
  • 批准号:
    24K19287
  • 财政年份:
    2024
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Community-based Preconception Lifestyle Intervention to prevent Gestational Diabetes Mellitus in Women living in India
以社区为基础的孕前生活方式干预,以预防印度妇女妊娠期糖尿病
  • 批准号:
    494564
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Operating Grants
Linoleic acid-derived oxylipin species and cognitive function in type 2 diabetes mellitus
亚油酸衍生的氧脂素种类与 2 型糖尿病的认知功能
  • 批准号:
    495437
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
Control mechanisms of lung adenocarcinoma by SGLT2 inhibitors for treating diabetes mellitus.
SGLT2抑制剂治疗糖尿病对肺腺癌的控制机制。
  • 批准号:
    23K08326
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Therapeutic efficacy of dapagliflozin, a selective inhibitor of sodium–glucose co-transporter type 2, for chronic heart failure in Japanese patients with type 2 diabetes mellitus
选择性钠抑制剂达格列净的治疗效果
  • 批准号:
    23K06224
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Pathophysiological analysis of the beta cell volume change elicited by pregnancy and gestational diabetes mellitus in Japanese pregnant women
日本孕妇妊娠和妊娠糖尿病引起的β细胞体积变化的病理生理学分析
  • 批准号:
    23K08020
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of CXCL10-CXCR3 axis in the compounding effects of diabetes mellitus in periodontitis
CXCL10-CXCR3轴在糖尿病牙周炎复合作用中的作用
  • 批准号:
    10740433
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
The Study of the Association between Gestational Diabetes Mellitus and Mental Health during Pregnancy in Japanese Women
日本女性妊娠期糖尿病与孕期心理健康关系的研究
  • 批准号:
    23K10101
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Personalized diet therapy useful for glycemic control and quality of life in patients with type 1 diabetes mellitus
个性化饮食疗法有助于 1 型糖尿病患者的血糖控制和生活质量
  • 批准号:
    23K10809
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidating the Pathophysiology of Gestational Diabetes Mellitus
阐明妊娠糖尿病的病理生理学
  • 批准号:
    10738361
  • 财政年份:
    2023
  • 资助金额:
    $ 19.88万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了